Bästa Novartis podcaster (2024)

1
NUKED: Our nuclear future, with Novartis, Wilsons Advisory and Cyclotek 34:16

6d ago34:16

34:16

Drone-deliveries of radioactive medicines and diagnostics to Australia's far-flung towns. Radiopharmaceuticals matched with genetic information to tailor precisely the right dose and isotope to a person's cancer. Pan-cancer drugs that fix many tumours, not just one. Miniature particle accelerators. These are the hopes, dreams and expectations we ca…

1
#135: Eric Kapitulik — Founder and CEO of The Program, Fmr. Platoon Commander in the 1st Force Recon USMC, author of The Program: Lessons from Elite Military Units 50:57

4d ago50:57

50:57

One major trait for many great leaders is the ability to not just persevere through hard times, but create an opportunity during challenging times. Eric Kapitulik really, really knows something about that. A graduate of the United States Naval Academy, where he was a four year varsity player in D1 Lacrosse, he then went on to serve in the United St…

1
Achieving Health Equity Through All-Payer Models with Dr. Trudy Hall 49:21

1d ago49:21

49:21

🎙 ABOUT DR. TRUDY HALL Dr. Trudy R. Hall has been the Vice President of Medical Affairs and Chief Medical Officer at TidalHealth since July 2022. She previously served in leadership roles at the University of Maryland's Capital Region Health and other UM health centers, overseeing major facilities, including a 345-bed COVID care site during the pan…

1
Ep 236 "Perspectives on Treatment Developments for Psoriatic Disease" 26:28

6d ago26:28

26:28

Over 20 years ago biologics were introduced for psoriasis and PsA. Since then even more targeted treatments have been introduced. Listen as dermatologist Dr. Steven Feldman from Wake Forest University School of Medicine, shares his perspectives on the latest treatments, resident memory T-cells, and what's to come (such as an oral IL-23 agent) with …

1
Ep. 69 - Lee Fleisher: An Insider’s Account of CMS’s Alzheimer’s Coverage Decisions 34:36

11d ago34:36

34:36

CMS’s controversial decision to restrict access to Alzheimer’s mAb treatments, including Aduhelm, approved under FDA’s accelerated pathway was a unique case that is unlikely to set a precedent, former CMS CMO Lee Fleisher told BioCentury. “I do not think this will be repeated,” he said. In an interview with The BioCentury Show's Steve Usdin, Fleish…

1
Looking Outside Investigations & Interrogations: Greg Kading, Retired LAPD Detective 36:39

11d ago36:39

36:39

Investigating for the hidden truth, putting the puzzle pieces together, building a strong case, leading with objectivity … you might be thinking of the responsibility of business leaders. But today, we’re exploring these same familiar elements from the perspective of a field where this holds greater weight. We’re speaking about investigations & int…

1
NUKED: Patent puzzles, with FB Rice 25:20

13d ago25:20

25:20

The rule of thumb in biotech is that it costs around $1 billion to bring a new therapy from lab to market. Protecting that investment is the patent system. But what if part of your product is not made by your contract manufacturer, but by the people who are giving it to patients? Ie, their doctors. We explore an example in Australia where this push…

1
Ep. 235 "Is It Plaque Psoriasis? Recognizing and Managing the Disease in Skin of Color" a Johnson & Johnson-sponsored episode 30:03

13d ago30:03

30:03

Patient advocate Alisha Bridges and dermatologist Dr. Mona Shahriari discuss a study dedicated to people of all skin tones who have moderate to severe plaque psoriasis. Dr. Shahriari also shares her experience guiding people with skin of color as they navigate their psoriasis journey. This episode is sponsored by Johnson & Johnson. Please see Impor…

1
Ep. 234 "Psoriasis: It's More Than Skin Deep" 30:38

18d ago30:38

30:38

Psoriasis is not just a skin disease. It's about inflammation. Listen as dermatologist Dr. Chesahna Kindred at Kindred Hair and Skin Center, and moderator Michelle Zimmerman discuss related diseases that people with psoriasis are at risk of developing like uveitis, heart disease, IBD, PsA and more. Hear what screenings and actions you can take to c…

1
NUKED: Australia the nuclear power, with entX and Cyclowest 29:58

20d ago29:58

29:58

Can Australia create a mine to lab to bedside production line for radiopharmaceutical medicine? It has the reactor, biotechs and the hospitals to do that last two, and even has a growing pool of expertise to run these. What it doesn't have, yet, is many advanced manufacturers to do the first bits, the critical parts such as sifting through old mine…

1
Ep. 68 - Inside BeiGene: CEO John Oyler on Owning the Drug Development Process 35:08

25d ago35:08

35:08

Few CEOs have built a $20 billion biotech in under 15 years, as John Oyler has with BeiGene, managing to stay in that market cap band even through the downmarket. His strategy, to own clinical trials and manufacturing early on, looks particularly prescient in light of the cost and supply constraints threatening many biotechs today. On this episode …

1
Repairing Fragmented Care with Value-Based Strategies with Dr. Kamal Golla 46:51

25d ago46:51

46:51

🎙 ABOUT DR VISHNUKAMAL GOLLA Dr. Vishnukamal Golla is the medical director for value transformation at Evolent, a specialty and primary care management company. In this role, Dr. Golla leads the implementation of innovative value-based care models in specialty care. In helping Evolent manage approximately $1 billion of risk-based oncology and cardi…

1
NUKED: The IP game, with Clarity Pharmaceuticals and Radiopharm Theranostics 26:25

27d ago26:25

26:25

The question we are dancing around in episode 3 of NUKED is whether locking down isotopes supply chains are really the only way to play the radiopharmaceutical game. We ask Clarity Pharmaceutical executive chair Alan Taylor and Radiopharm Theranostics executive chair Paul Hopper how their companies are instead owning the IP, or banking a portfolio …

1
Ep 233 "Q&A About Plaque Psoriasis" 35:54

27d ago35:54

35:54

Moderator Renee Joyce asks dermatologist Dr. James Song at Frontier Dermatology Partners for his response to questions from you, our listeners like: What triggers psoriasis and how to avoid it? Can diet help scalp psoriasis? How to treat psoriasis on the face, neck or in the mouth? What type of psoriasis makes you prone to PsA? What's Woronoff's ri…

1
NUKED: Access is everything, with GlyTherix and Telix Pharmaceuticals 29:47

1M ago29:47

29:47

In early 2023, one of the first two really big radiopharmaceutical drugs ran into a problem. Novartis' prostate cancer therapy Pluvicto, released only the year before, was suddenly in short supply, snarling up just in time treatment schedules. In 2024 the supply chain problem is with the isotope Actinium 225, which *everyone* wants for clinical tri…

1
Looking Outside Brand Building: Oana Leonte, Founder unmtchd.brands 36:22

1M ago36:22

36:22

Today we’re looking outside a very familiar topic, exploring brand building that strengthens a brand’s equity today and sets it up for the future. We’re joined for this all-marketing chat with marketing rockstar, fellow podcaster, Founder of unmtchd.brands and former Puma exec, Oana Leonte. Oana recently pivoted from a marketing career working to b…

1
Episode #23 - Ellen Donnelly (Partner, DG Advisors, New York, NY) 44:02

1M ago44:02

44:02

Tune in now to meet @Ellen Donnelly, Partner, DG Advisors in New York, NY Join us to celebrate Ellen's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Ellen's for being such an inspiring role model! It's Time To Launch Connections To Ignite Your Success! Are you Ready!!! Watc…

1
Ep 67 - AAM's Craig Burton on Opportunities, Challenges of U.S. Biosimilars Market 28:51

1M ago28:51

28:51

There is good news in this year’s Association for Accessible Medicines report on savings from biosimilars, including a 30% increase over the last year in savings attributed to biosimilars. The report also explores the economic, policy and regulatory headwinds that are preventing the industry from generating savings at a level that would have a dram…

1
NUKED: Why radiopharmaceuticals are exploding, with Peter MacCallum Cancer Centre and HB Biotechnology 25:34

1M ago25:34

25:34

The radiopharmaceuticals sector is on a knife point. The scope of what nuclear medicine can do is exploding. But the radioisotopes that biotechs need to make those therapies are in very, very short supply. Major clinical trials are hitting pause because of shortages of critical nuclear isotopes, and the world's biggest pharmaceutical companies are …

1
The Silent Killer: The sci-fi episode, with Certa Therapeutics and University of Sydney CTC 27:59

2M ago27:59

27:59

Wearable kidneys. Organs on a chip. Xenotransplantation. The future is here. But is that the future people in biotech are truly looking to? Because the future that Certa Therapeutics CEO Darren Kelly is looking to is much less 1980s sci-fi and more... Apple watch. And in a future where the numbers point to a rise in lifestyle diseases thanks to die…

1
Ep. 232 "Living with Generalized or Palmoplantar Pustular Psoriasis?" 33:58

2M ago33:58

33:58

Living with pustular psoriasis is tough. Hear the latest updates about heritable aspects of GPP, diagnosis, management tips, and treatment options such as the IL-36 inhibitor spesolimab, how it works and how effective it is from dermatologist Dr. Laura Ferris, Professor of Dermatology at the University of Pittsburgh and moderator Alan Simmons. This…

1
Episode #22 - Dr. Jim Strong (Provost and Vice President of Student Affairs (retired) - California State University - Stanislaus 35:35

2M ago35:35

35:35

Tune in now to meet @Jim Strong, Provost and Vice President for Academic Affairs (retired) and Professor of Marketing at California State University - Stanislaus. Join us to celebrate Jim's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Jim's for being such an inspiring role…

1
Popular Episode - Bob Nelsen on AI, China and the IRA 35:33

2M ago35:33

35:33

This is a previously recorded episode of The BioCentury Show from February 22, 2024. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes. In a wide-ranging conversation with BioCentury, Bob Nelsen, co-founder and managing director of Arch Venture Partners, said he is excited…

1
The Silent Killer: Prevention is the next cure, with Kidney Health Australia and Proteomics International 23:06

2M ago23:06

23:06

We may have led you on a bit in the first two episodes... kidney disease is still a big problem despite the massive shifts forward in treating it. There is a long way to go to bring medical sectors -- and governments -- along as well. This episode features Breonny Robson, general manager of clinical and research at Kidney Health Australia and Richa…

1
Ep. 231 "The 'PSConnection': Understanding the Potential Link Between Psoriasis and Psoriatic Arthritis" A Novartis-sponsored episode 27:41

2M ago27:41

27:41

Join NPF moderator LB Herbert as NPF patient volunteers Sam Blonien and Jeff Brown get candid about their experience living with psoriasis (PsO) and psoriatic arthritis (PsA). Hear from Sam and Jeff, along with commentary from Dr. Andrea Murina, on the potential connection between PsO and PsA, the importance of finding the right doctor, and where t…

1
Advancing Medicine With Placenta-Derived Cells with Dr. Robert Hariri 1:00:35

2M ago1:00:35

1:00:35

🎙ABOUT DR. ROBERT HARIRI: Dr. Bob Hariri is a pioneering surgeon, biomedical scientist, and serial entrepreneur with expertise in biomedicine and aerospace. He is the founder, chairperson, and CEO of Celularity, Inc., a leader in human cellular therapeutics, and previously founded Anthrogenesis Corporation, which was acquired by Celgene, where he s…

1
The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics 24:40

2M ago24:40

24:40

We speak to Dimerix CEO Dr Nina Webster about why investors are thrilled with her company, as it nears the midway point for its Phase III clinical trial for the rare disease focal segmental glomerulosclerosis (FSGS). And we talk to PYC Therapeutics CEO Dr Rohan Hockings about how his company's tech actually works to treat polycystic kidney disease.…

1
A journey to leadership: a chat with visionary leader and role model Raj Bhogal. 58:52

2M ago58:52

58:52

A journey to leadership; a chat with visionary global leader and role model Raj Bhogal, currently @Jazz Pharmaceuticals strategising and making things happen! This is a wonderful discussion highlighting how to drive forward your career and create opportunities for yourself. However, there is so much more that we cover in this episode and some of th…

1
Ep. 66 - Jane Grogan on Building Biogen’s Growth Engine 32:23

2M ago32:23

32:23

As Jane Grogan anticipates the unmet needs in patients five years from now, she’s harnessing a wave of interest in targeting B cells as a key driver of an immunology expansion at Biogen. In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Grogan, who became EVP and head of research of Biogen in October, discusses how she’s …

1
Driving Better Outcomes with Ambulatory Surgical Centers 54:26

2M ago54:26

54:26

ABOUT ARIC BURKE Aric brings over eighteen years of experience in ASC consulting, development, and operations. He oversees the strategic vision, operational management, and organizational structure of Atlas, driving its profitability and strategic direction. Before founding Atlas, Aric was the West Market President for United Surgical Partners Inte…

1
The Silent Killer: Why biotechs are all in on kidney disease, with University of Sydney CTC and Chris Kallos 26:54

2M ago26:54

26:54

Kidney disease is a silent killer, with only 10% of all people knowing they have it before damage has been done. But in the last five years there's been a surge of work that's resulted in the FDA approving some blockbuster drugs in the last 18 months. Billion-dollar takeovers are now on the table and the tiny number of Australian biotechs in this s…

1
Looking Outside Insights BS: Ryan Barry, President Zappi 37:35

2M ago37:35

37:35

Today we’re taking a no BS look at the world of customer insights, leadership and business visioning with the President of software company Zappi, the ever-passionate and transparent leader, Ryan Barry. Having led Zappi for over four years, Ryan shares his no holds barred take on company leadership and people leadership, and it’s all anchored on au…

1
Episode #21 - Dr. Jerry Jakubowski (Provost and VP Student Affairs (retired) at California Maritime Academy) 29:42

3M ago29:42

29:42

Tune in now to meet Dr. Jerry Jakubowski, Provost and Vice President for Academic Affairs (retired) at California Maritime Academy in Vallejo, CA. Join us to celebrate Jerry's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Jerry for being such an inspiring role model! It's T…

1
Ep 230 "Is My Psoriasis Flare Due to Medications I'm Taking?" 20:54

3M ago20:54

20:54

Is it possible your flare of psoriasis is due to products or medications you use? Learn what medications for high blood pressure, depression, anxiety, pain (NSAIDS), or infection can potentially flare psoriasis, and what paradoxical psoriasis is from Clinical Dermatology Pharmacist Lacey Glover, Pharm.D., University of Alabama Medicine, and moderat…

1
Phase III Trailer 0:39

3M ago0:39

0:39

Life sciences more than anywhere else is the successful mashup of money and tech. I'm Rachel Williamson and this is Phase III, a weekly podcast diving deep into Australian life sciences. In each of our short series, we investigate, interrogate, and explore the most exciting companies and ideas in health science and the investment case for what they…

1
Ep. 65 - Astellas' Claus Zieler: Global Launches with Local Impact 32:27

3M ago32:27

32:27

As Astellas prepares to launch four products in parallel, Chief Commercial Officer Claus Zieler is balancing the complexity of this multi-faceted enterprise with a simple guiding principle: it has to work at a local level, and that will change with geography, circumstance and time. In conversation with Editor in Chief Simone Fishburn on The BioCent…

1
#134: Corey Mintz — Freelance Food Reporter for The New York Times, Eater and more, Hospitality Operations Advisor, author of ‘The Next Supper: The End of Dining as we Know It’ 26:36

3M ago26:36

26:36

2024 is going to be remembered for a lot of things, one of them being that it was the year we finally moved past the COVID-19 Pandemic. Industries everywhere are claiming to ‘be back’ to pre-pandemic functions, with everything from return to office initiatives to the National Restaurant Association boasting that restaurants are back to 2019 rates o…

1
Looking Outside Plant-Based Food: Marc Coloma, CEO Heura & Food Activist 44:03

3M ago44:03

44:03

In this episode, we’re taking a look outside the very familiar food industry and a closer look at the emerging sector of plant-based food, with food activist, entrepreneur, and CEO and Co-Founder of Heura, Marc Coloma. Marc’s mission to transform the food industry starts with his own company, which acts as a symbol for what is possible; investing i…

1
Ep 229 "Shining New Light on Phototherapy for Psoriasis: Results of the Light Treatment Effectiveness Study" 23:17

3M ago23:17

23:17

Hear results from the Light Treatment Effectiveness (LITE) Study comparing home vs office based phototherapy for psoriasis with renowned dermatologist Dr. Kristina Duffin, Chair, Dept. of Dermatology, University of Utah, as she discusses benefits, innovations, and barriers with Dr. Guy Eakin, NPF Chief Scientific & Medical Officer. The LITE Study i…

1
Ep. 64 - NPC CEO John O’Brien: Why America Needs an Honest Conversation About Drug Pricing 33:36

3M ago33:36

33:36

Ignorance about the path from scientific discovery to approved drugs, high out-of-pocket costs, and a byzantine healthcare system that obscures net prices while inflating list prices have fueled policies that threaten biomedical progress, John O’Brien, CEO of think tank National Pharmaceutical Council, told BioCentury. In an interview with The BioC…

1
Ep. 228 "A Future Free From Psoriatic Disease: The New NPF Strategic Plan" 30:39

4M ago30:39

30:39

Over the past year NPF has gathered insights from the psoriatic disease community to develop a new 5 year strategic plan. Join Matt Werbach, NPF Associate Director of Media and Communications as he speaks with NPF President and CEO Leah Howard, and Board Member Rick Seiden about the plan, milestones towards a cure, and steps to help improve the hea…

1
Episode #20 - Bill Yosses (Executive Chief and Former White House Pastry Chief, New York, NY) 36:52

4M ago36:52

36:52

Tune in now to meet Bill Yosses, Executive Chief in New York City. Bill has owned and operated restaurants in NYC and served as Executive Pastry Chief at The White under Presidents Bush and Obama. Join us to celebrate Bill's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Bil…

1
Ep. 63 - Day One's Jeremy Bender: Building Pediatric Oncology from the Ground Up 32:27

4M ago32:27

32:27

Pediatric cancer drug development is difficult: it requires high levels of safety, involves parents as well as the patients, and has small populations that can make it difficult to achieve the revenues that reward the investment. Squaring that circle, according to Day One Biopharmaceuticals CEO Jeremy Bender, is not impossible, but takes a dedicate…

1
#133: Amy Edmondson — Novartis Professor of Leadership and Management at the Harvard Business School, author of “Right Kind of Wrong: The Science of Failing Well” 27:21

4M ago27:21

27:21

For any long time listeners of the podcast, you know we are firm believers in failure being a positive thing. From D1 coaches to cutting edge researchers, great performers and leaders across the board understand the importance of allowing people to fail well. But, how exactly do you do that? Enter today’s guest Amy Edmondson, Novartis Professor of …

1
Looking Outside Imperfect Stories: Marco Andre, Head of Marketing & Gen AI, Novartis 40:22

4M ago40:22

40:22

In this episode of Looking Outside, we explore personal and professional growth from the angle of imperfection; not having it all figured out and embracing what you don’t know as a lever for learning. Even if you work for the world’s biggest and best brands. Just like our guest has done, Marco Andre, author of Imperfect Stories and Head of Marketin…

1
Working with IDNs: The Pharma Perspective 1:12:50

4M ago1:12:50

1:12:50

ABOUT HEALTH CARE ROUNDS Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments. ABOUT MATT PORTCH Matt Portch is…

1
Episode #19 - Al Thigpen (Lead Operating Partner, Nautic Partners, Chicago, IL) 38:45

4M ago38:45

38:45

Tune in now to meet Al Thigpen, Lead Operating Partner for Nautic Partners in Chicago. He also serves as Chair of The Board of Directors for EmpiRX Health and is a board member of multiple other pharmaceutical and healthcare companies. Join us to celebrate Al's life journey and learn about the power of using The Threads of Connectivity to build you…

1
Ep 227 "Our Tips for Managing Psoriasis and Life Together" 37:30

4M ago37:30

37:30

Being a couple has its challenges. When do you let someone know you have psoriasis? What do you do to be a great partner? Hear Licensed Professional Counselor Mary Maraventano Stried chat with Lori and Howard Chang, who has had psoriasis for 45 years, about key ingredients to navigating life together for 30 years from acceptance, open communication…

1
Ep. 62 - Rick Bright: Navigating the Avian Flu Threat 40:22

4M ago40:22

40:22

The U.S. is experiencing events that are either the first stages of a widespread avian influenza outbreak or a fire drill that will show how well the nation is prepared for an outbreak. The U.S. has not stepped up to meet the challenge, Rick Bright, the former director of BARDA, told BioCentury. In an interview with The BioCentury Show's Steve Usdi…

1
Episode #18 - Roquel Cunningham Bush (Project Manager, Sequoia, Dallas, TX) 39:45

4M ago39:45

39:45

Tune in now to meet Roquel Cunningham Bush, Project Manager at Sequoia in Dallas, TX. Join us to celebrate Roquel's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Roquel for being such an inspiring role model! It's Time To Launch Connections To Ignite Your Success! Are you R…

Podcaster värda att lyssna på

Novartis podcaster

Podcaster värda att lyssna på

Snabbguide